Use of direct oral anticoagulants in antiphospholipid syndrome: Reply

被引：4
作者：
Cohen, Hannah [1 ,2 ]
Efthymiou, Maria [2 ]
Isenberg, David A. [3 ,4 ]
机构：
[1] Univ Coll London Hosp NHS Fdn Trust, Dept Haematol, London, England
[2] UCL, Dept Haematol, Haemostasis Res Unit, 1st Floor,51 Chenies Mews, London WC1E 6HX, England
[3] UCL, Ctr Rheumatol, Div Med, London, England
[4] Univ Coll London Hosp NHS Fdn Trust, Dept Rheumatol, London, England
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2020年 / 18卷 / 01期
关键词：
antiphospholipid syndrome; arterial thrombosis; direct oral anticoagulants; triple positive antiphospholipid antibodies; venous thromboembolism; vitamin K antagonists'; ED AMERICAN-COLLEGE; ANTITHROMBOTIC THERAPY; PREVENTION; MANAGEMENT; THROMBOSIS;
D O I：
10.1111/jth.14674
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：259 / 261
页数：3
相关论文
共 50 条
  • [11] Rethinking the use of direct oral anticoagulants for secondary thromboprophylaxis in patients with thrombotic antiphospholipid syndrome
    Franco-Moreno, Anabel
    Izquierdo-Martinez, Aida
    Ancos-Aracil, Cristina
    DRUG DISCOVERIES AND THERAPEUTICS, 2024, 18 (04) : 213 - 219
  • [12] Direct oral anticoagulants: an alternative treatment for thrombotic antiphospholipid syndrome?
    Resseguier, A. S.
    Pereira, B.
    Rieu, V.
    Le Guenno, G.
    Grobost, V.
    Ruivard, M.
    LUPUS, 2017, 26 (12) : 1297 - 1303
  • [13] Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature
    Marco-Rico, Ana
    Marco-Vera, Pascual
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2023, 49 (07) : 736 - 743
  • [14] Use of New Oral Anticoagulants in Antiphospholipid Syndrome
    Arachchillage, Deepa Jayakody
    Cohen, Hannah
    CURRENT RHEUMATOLOGY REPORTS, 2013, 15 (06)
  • [15] Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature
    Dufrost, Virginie
    Risse, Jessie
    Zuily, Stephane
    Wahl, Denis
    CURRENT RHEUMATOLOGY REPORTS, 2016, 18 (12)
  • [16] Direct oral anticoagulants in patients with antiphospholipid syndrome: a retrospective study in a real-life patient cohort
    Franke, Benjamin
    Luxembourg, Beate
    Heidinger, Kathrin
    Kemkes-Matthes, Bettina
    Sachs, Ulrich J.
    BLOOD COAGULATION & FIBRINOLYSIS, 2022, 33 (03) : 184 - 187
  • [17] Cessation of oral anticoagulants in antiphospholipid syndrome
    Comarmond, C.
    Jego, P.
    Veyssier-Belot, C.
    Marie, I.
    Mekinian, A.
    Elmaleh-Sachs, A.
    Leroux, G.
    Saadoun, D.
    Oziol, E.
    Fraisse, T.
    Hyvernat, H.
    Thiercein-Legrand, M-F
    Sarrot-Reynauld, F.
    Ferreira-Maldent, N.
    de Menthon, M.
    Goujard, C.
    Khau, D.
    Nguen, Y.
    Monnier, S.
    Michon, A.
    Castel, B.
    Decaux, O.
    Piette, J-C
    Cacoub, P.
    LUPUS, 2017, 26 (12) : 1291 - 1296
  • [18] Direct Oral Anticoagulants in Antiphospholipid Syndrome-Associated Venous Thromboembolism: Real World Evidence
    Hwang, Hun-Gyu
    Lee, Ju Hyun
    Kim, Sang-A
    Kim, Yang-Ki
    Kim, Myung-Shin
    Hong, Junshik
    Yhim, Ho-Young
    Bang, Soo-Mee
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2024, 39 (36)
  • [19] Direct oral anticoagulants versus vitamin K antagonists in antiphospholipid syndrome: A meta-analysis.
    Cerda, Pau
    Becattini, Cecilia
    Iriarte, Adriana
    Hernandez, Josefina Cortes
    Corbella, Xavier
    Riera-Mestre, Antoni
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 79 : 43 - 50
  • [20] Treatment of the antiphospholipid syndrome with direct oral anticoagulants Position statement of German societies
    Bauersachs, Rupert
    Langer, Florian
    Kalka, Christoph
    Konstantinides, Stavros
    Klamroth, Robert
    Oldenburg, Johannes
    Schellong, Sebastian
    Scholz, Ute
    Stuecker, Markus
    Lindhoff-Last, Edelgard
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2019, 48 (06) : 483 - 486
12345